Methods of following drug release from controlled release dosage formsGOULD, P. L.British polymer journal. 1983, Vol 15, Num 4, pp 172-176, issn 0007-1641Article

A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materialsGAVIN, Peter F; OLSEN, Bernard A; WIRTH, David D et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1251-1259, issn 0731-7085, 9 p.Article

Physical approaches for the delivery of active ingredients in foodsUBBINK, Job; KRÜGER, Jessica.Trends in food science & technology (Regular ed.). 2006, Vol 17, Num 5, pp 244-254, issn 0924-2244, 11 p.Conference Paper

Natural plant chemicals: sources of industrial and medicinal materialsBALANDRIN, M. F; KLOCKE, J. A; WURTELE, E. S et al.Science (Washington, D.C.). 1985, Vol 228, Num 4704, pp 1154-1160, issn 0036-8075Article

Pharmaceutical applications of functionalized polymersPETRAK, K.Reactive polymers. 1989, Vol 10, Num 2-3, pp 231-237, issn 0923-1137, 7 p.Conference Paper

THE PROBLEM OF GENERICS.FROMMING KH.1976; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1976; VOL. 14; NO 4; PP. 242-244Article

» Physical Active Ingredients« for Wrinkle ReductionBÄNZIGER, S; OBERMAYER, B.SÖFW-Journal. 2012, Vol 138, Num 4, issn 0942-7694, 24-32 [6 p.]Article

Active pharmaceutical ingredientsSTOKER, Andy.Chemical engineer (London). 2002, Num 732, pp 38-39, issn 0302-0797Article

Drug glycosides: potential prodrugs for colon-specific drug deliveryFRIEND, D. R; CHANG, G. W.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 1, pp 51-57, issn 0022-2623Article

Flavonoïdes de glycoxylon huberi Ducke = Flavonoids from Glycoxylon huberi DuckeJACQUEMIN, H; BOISSONNAT, A; FAUGERAS, G et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 5, pp 521-525, issn 0003-4509Article

Sur la résine d'Epema grandiflora (Aublet) Benth. (Légumineuses césalpiniacées) = Resin of Eperna grandiflora (Aublet) Benth. (Caesalpiniaceae)GOURNELIS, D; VIDAL-TESSIER, A. M; DELAVEAU, P et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 6, pp 565-572, issn 0003-4509Article

Zur Liberation von wasserlöslichen Wirkstoffen aus Polymereinbettungen. II: Die Bedeutung der durch technologische Verfahren bedingten Makrostruktur der Einbettungsarzneiformen für die Wirkstoffliberation = La libération des substances solubles dans l'eau à partir d'inclusions dans des polymères II. L'importance de la macrostructure des formes médicamenteuses incluses déterminée par le procédé technologique sur la libération du principe actif = On the liberation of water-soluble active agents from polymer embeddings Part 2: The importance of the manufacturing-process dependent macrostructure of the embedded dosage form in active agent liberationSÜSS, W.Pharmazie. 1983, Vol 38, Num 9, pp 601-607, issn 0031-7144Article

Release of ergotamine from poly (2-hydroxyethyl methacrylate)HUGLIN, M. B; SLOAN, D. J.British polymer journal. 1983, Vol 15, Num 4, pp 165-171, issn 0007-1641Article

Marketing issues in bulk active ingredients. Contact manufacturingBOZZOLI, V.Chimica oggi. 1992, Vol 10, Num 1-2, pp 67-68, issn 0392-839XArticle

Factorial design of experiment for stability studies in the development of a tablet formulationEL-BANNA, H. M; ISMAIL, A. A; GADALLA, M. A. F et al.Pharmazie. 1984, Vol 39, Num 3, pp 163-165, issn 0031-7144Article

The targeting of drugs using polymeric microspheresDAVIS, S. S; ILLUM, L.British polymer journal. 1983, Vol 15, Num 4, pp 160-164, issn 0007-1641Article

Analisis cualitativo y cuantitativo del sulfato de 8-hidroxiquinoleina monohidrato = Analyse qualitative et quantitative du sulfate de 8-hydroxyquinoléine monohydrate = Qualitative and quantitative analysis of sulfate of 8-hydroxyquinoline monohydratedMINGOT LORENZO, M; RUPEREZ CUENCA, M. M.1983, Num 13, 11 p.Serial Issue

Einfluss der Lagerung auf den Arzneistoffgehalt und dessen Freigabeverhalten aus Perlpolymerisation = Influence du stockage sur la composition et la libération du médicament à partir de perles de polymères = Influence of the storage on the drug content and on the release of the drug from bead polymersMANK, R; KALA, H.Pharmazie. 1984, Vol 39, Num 3, pp 166-167, issn 0031-7144Article

Non-irritant concentrations and amounts of active ingredient in drug patch testsBRAJON, Delphine; MENETRE, Sophie; WATON, Julie et al.Contact dermatitis. 2014, Vol 71, Num 3, pp 170-175, issn 0105-1873, 6 p.Article

Ingrédients nouveaux = New ingredientsParfums cosmétiques actualités. 2005, Num 181, pp 78-79, issn 1267-0812, 2 p.Article

Les collyres et leur biodisponibilité = The eye drops and their biodisponibilityFAURE, M.La Clinique ophtalmologique. 1987, Num 2, pp 137-143, issn 0009-9368, 6 p.Article

Alcaloïdes de Neisosperma kilneri (F.V. Mueller) Fosbert et Sachet = Alkaloids from Neisosperma kilneri (F.V. Mueller) Fosberg et SachetBATCHILY, F; MEHRI, H; PLAT, M et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 5, pp 513-520, issn 0003-4509Article

Release of hydrocortisone and hydrocortisone acetate from topical vehicles in vitroTURAKKA, L; PIEPPONEN, T; KAHELA, P et al.Labo Pharma, problèmes et techniques. 1984, Vol 32, Num 344, pp 540-544, issn 0458-5747Article

Möglichkeiten zur Bestimmung der Wirkstoffreigabe aus hydrophoben Trägern, insbesondere aus Suppositorien = Possibilités pour la détermination de la libération de principe actif à partir de supports hydrophobes en particulier à partir des suppositoires = Alternative technique for the determination of drug release from hydrophobic matrix particularly suppositoriesDIBBERN, H.-W; WIRBITZKI, E.Pharmazeutische Industrie. 1983, Vol 45, Num 10, pp 985-990, issn 0031-711XArticle

Deklaration kosmetischer Mittel nach INCI = Declaration of cosmetics according to INCIHUBER, B.SÖFW. Seifen, Öle, Fette, Wachse. 1996, Vol 122, Num 2, pp 99-100, issn 0173-5500Article